RosettaSearch: Multi-Objective Inference-Time Search for Protein Sequence Design

The headline numbers (2.5x success rate, 18-68% structural fidelity gains) describe improvement over single-pass baselines, but the paper's real contribution is architectural: it borrows the inference-time compute scaling logic from language reasoning research and applies it to a domain where each 'token' is an amino acid with physical consequences. The cost of that extra compute at inference time, and whether it's practical for real lab pipelines, is not addressed in the summary.

This sits at an interesting intersection with two threads we've been tracking. The inference-time search framing maps directly onto IG-Search (covered April 16), which rewards LLMs for iterative retrieval using step-level signals rather than single-pass generation. RosettaSearch applies the same intuition to protein sequences: don't commit to one output, search the space. More directly, OpenAI's GPT-Rosalind launch (April 16) signals that large labs are also targeting protein research workflows, which means RosettaSearch's academic approach will soon compete with well-resourced proprietary pipelines for adoption in pharma and biotech settings.

Watch whether any wet-lab validation of RosettaSearch-designed proteins appears in preprints within the next six months. Computational success rates on 400 test cases are meaningful, but the benchmark only confirms the model agrees with itself. Experimental binding or folding confirmation would be the first real signal.